论文部分内容阅读
目的探讨缬沙坦联合苯磺酸左旋氨氯地平治疗老年原发性高血压的疗效。方法选取老年原发性高血压患者98例,随机分为缬沙坦联合苯磺酸左旋氨氯地平组32例(A组)、缬沙坦组33例(B组)和苯磺酸左旋氨氯地平组33例(C组)。三组分别给予上述药物降压治疗,28d为1个疗程。观察三组治疗后降压效果及不良反应。结果治疗28d,三组SBP、DBP均下降,与治疗前比较,差异有统计学意义(P<0.05);A组SBP、DBP下降水平优于B、C组(P<0.05)。A、B、C组总有效率分别为96.9%、75.8%、72.7%(P<0.05)。三组治疗过程中均无严重不良反应发生。结论缬沙坦联合苯磺酸左旋氨氯地平治疗老年原发性高血压降压效果优于两种药物单独应用,临床效果好。
Objective To investigate the efficacy of valsartan combined with levamlodipine besylate in the treatment of senile essential hypertension. Methods A total of 98 elderly patients with essential hypertension were randomly divided into valsartan and levamlodipine besylate group, 32 cases (group A), valsartan group (33 cases, group B) and levamisole Chlorpheniramine in 33 cases (C group). Three groups were given antihypertensive treatment of the above drugs, 28d for a course of treatment. Observe the antihypertensive effects and adverse reactions of three groups after treatment. Results The SBP and DBP of three groups decreased on the 28th day after treatment. Compared with those before treatment, the difference was statistically significant (P <0.05). The decrease of SBP and DBP in group A was better than that in group B and C (P <0.05). The total effective rates in groups A, B and C were 96.9%, 75.8% and 72.7%, respectively (P <0.05). No serious adverse reactions occurred in the three groups during the treatment. Conclusion Valsartan combined with levamlodipine besylate in the treatment of senile essential hypertension has better antihypertensive effects than the two drugs alone, with good clinical effect.